| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 3.130 | 3.288 | 3.899 | 6.178 | 1.314 | 3.637 | 3.629 | 5.066 |
| Total Income - EUR | - | - | 3.130 | 3.288 | 3.899 | 6.178 | 1.314 | 3.637 | 3.629 | 5.279 |
| Total Expenses - EUR | - | - | 4 | 719 | 425 | 469 | 446 | 149 | 1.196 | 734 |
| Gross Profit/Loss - EUR | - | - | 3.127 | 2.568 | 3.473 | 5.709 | 868 | 3.488 | 2.433 | 4.545 |
| Net Profit/Loss - EUR | - | - | 3.033 | 2.470 | 3.356 | 5.524 | 829 | 3.379 | 2.044 | 3.913 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Complex Amurg Colibita Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 17.428 | 17.090 | 16.766 | 16.394 | 16.445 | 16.220 | 16.100 |
| Current Assets | - | - | 16.233 | 1.483 | 4.856 | 10.495 | 2.122 | 1.710 | 308 | 1.753 |
| Inventories | - | - | 0 | 0 | 194 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 13.165 | 0 | 1.022 | 2.402 | 621 | 0 | 76 | 456 |
| Cash | - | - | 3.068 | 1.483 | 3.640 | 8.094 | 1.501 | 1.710 | 232 | 1.298 |
| Shareholders Funds | - | - | 3.077 | 5.490 | 8.740 | 14.097 | 14.613 | 11.954 | 13.962 | 17.796 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 13.156 | 13.421 | 13.207 | 13.164 | 3.903 | 6.201 | 2.565 | 57 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5520 - 5520" | |||||||||
| CAEN Financial Year |
5520
|
|||||||||
Comments - Complex Amurg Colibita Srl